ClinicalTrials.gov
ClinicalTrials.gov Menu

Personality Characteristics and Compliance With Antiglaucoma Medication (GDC)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00481494
Recruitment Status : Unknown
Verified May 2007 by Yonsei University.
Recruitment status was:  Recruiting
First Posted : June 1, 2007
Last Update Posted : June 1, 2007
Sponsor:
Information provided by:
Yonsei University

Brief Summary:
Personality traits may influence to the drug compliance in glaucoma patients.

Condition or disease
Glaucoma

Detailed Description:
In chronic diseases, especially asymptomatic at early stage, drug compliance has been reported as an important factor to control them. And personality traits are associated with the drug compliance. However, there was few study to consider this relationship. We want to find the association the personality characteristics and drug compliance in glaucoma patients.

Study Type : Observational
Estimated Enrollment : 150 participants
Time Perspective: Cross-Sectional
Time Perspective: Prospective
Official Title: Personality Characteristics and Compliance With Antiglaucoma Medication
Study Start Date : May 2007
Estimated Study Completion Date : October 2007

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Glaucoma
U.S. FDA Resources





Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   20 Years to 80 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Chronic glaucoma
  • Topical anti-glaucoma medications

Exclusion Criteria:

  • Oral glaucoma medications

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00481494


Contacts
Contact: Chan Yun Kim, MD, PhD 82-2-2228-3580 kcyeye@yumc.yonsei.ac.kr

Locations
Korea, Republic of
Severance Hospital, Yonsei University College of Medicine Recruiting
Seoul, Korea, Republic of, 120-752
Contact: Chan Yun Kim, MD, PhD    82-2-2228-3580    kcyeye@yumc.yonsei.ac.kr   
Sponsors and Collaborators
Yonsei University
Investigators
Study Chair: Chan Yun Kim, MD, PhD Department of Ophthalmology, Yonsei University College of Medicine

ClinicalTrials.gov Identifier: NCT00481494     History of Changes
Other Study ID Numbers: 4-2007-0092
First Posted: June 1, 2007    Key Record Dates
Last Update Posted: June 1, 2007
Last Verified: May 2007

Keywords provided by Yonsei University:
Glaucoma
Drug compliance
Personality

Additional relevant MeSH terms:
Glaucoma
Ocular Hypertension
Eye Diseases